JELD-WEN Holding Inc Stock News

JELD-WEN Holding (NYSE: JELD ) reported its Q4 earnings results on Tuesday, February 22, 2022 at 06:00 AM. Here''s what investors need to know about the announcement. Check out this: Insiders Buy More Than $170M Of 4 Stocks Earnings JELD-WEN Holding missed estimated earnings Full story available on Benzinga.com

JELD-WEN Holding press release (JELD): Q4 Non-GAAP EPS of $0.48 misses by $0.06.Revenue of $1.28B (+11.3% Y/Y) beats by $60M.2022 Outlook: Full year 2022 net revenue growth expected

Companies Reporting Before The Bell Gaotu Techedu (NYSE: GOTU ) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million. Sohu.com (NASDAQ: SOHU ) is expected to report earnings for its fourth quarter. Kiniksa Pharmaceuticals (NASDAQ: KNSA ) is likely to report quarterly loss at $0.42 per share on revenue of $20.72 million. Hecla Mining (NYSE: HL ) is expected to report quarterly earnings at $0.02 per share on revenue of $198.95 million. Standard Motor Products (NYSE: SMP ) is expected to report quarterly earnings at $0.67 per share on revenue of $282.91 million. KBR (NYSE: KBR ) is likely to report quarterly earnings at $0.65 per share on revenue of $2.53 billion. Fresenius Medical Care (NYSE: FMS ) is likely to report quarterly earnings at $0.49 per share on revenue of $5.22 billion. Ardagh Metal Packaging (NYSE: AMBP ) is expected to report quarterly earnings at $0.09 per share on revenue of $1.02 billion. Krispy Kreme (NASDAQ: DNUT ) is estimated to report quarterly earnings at $0.

JELD-WEN (JELD) delivered earnings and revenue surprises of -18.64% and 4.43%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

JELD-WEN (JELD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

JELD-WEN (JELD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CHARLOTTE, N.C., Feb. 11, 2022 /PRNewswire/ -- JELD-WEN Holding, Inc. (NYSE:JELD) today announced the participation in several upcoming investor conferences.

Weyerhaeuser (WY) delivered earnings and revenue surprises of 2.08% and 3.62%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

JELD-WEN Holding Inc. (JELD) shares closed 1.5% lower than its previous 52 week low, giving the company a market cap of $2B. The stock is currently down 11.5% year-to-date, down 16.9% over the past 12 months, and down 10.7% over the past five years. This week, the Dow Jones Industrial Average fell 2.5%, and the S&P 500 fell 4.1%. Trading Activity Trading volume this week was 32.0% higher than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 1.9. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Materials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -15.1% The company's stock price performance over the past 12 months lags the peer average by 51.3% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -12.4% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

The following two stocks have underperformed the broader market recently. They are also in financial distress, as represented by low Altman Z-Scores, meaning that they could go bankrupt within the nex

CHARLOTTE, N.C., Jan. 21, 2022 /PRNewswire/ -- JELD-WEN Holding, Inc. (NYSE: JELD) today announced that it will release fourth quarter and full year 2021 results before the market opens on Tuesday, F

SAN DIEGO, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Recludix Pharma, a leader in platform approaches to discover inhibitors of challenging cancer and inflammatory disease targets, today announced the establishment of its scientific advisory board. "We are thrilled to have established a group of distinguished scientific thought leaders as advisors to the company," said Nancy Whiting, Pharm.D., chief executive officer of Recludix. "Our scientific advisory board consists of pioneers in precision medicine for both oncology and inflammatory diseases. Their deep and diverse expertise will prove invaluable as we advance our pipeline of potent and selective oral inhibitors of important targets that have historically been challenging to drug." Brian Druker, M.D., director of the Knight Cancer Institute, associate dean for oncology, and JELD-WEN chair of leukemia research at the Oregon Health & Science University, added, "The differentiated development candidates being generated by Recludix''s platform to selectively inhibit the once-elusive, but critical, targets of STAT3 and STAT6 could yield transformational new therapies.

Zacks Investment Research upgraded shares of JELD-WEN (NYSE:JELD) from a hold rating to a buy rating in a research report report published on Tuesday, Zacks.com reports. They currently have $26.00 price target on the stock. According to Zacks, JELD-WEN Holding, Inc. designs, produces and distributes interior and exterior doors, wood, vinyl and aluminum windows and []

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest